Journal article
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.
Abstract
AIMS: There is conflicting evidence on whether in treated hypertensive patients the risk of renal outcomes is associated with visit-to-visit SBP variability. Furthermore, limited evidence is available on how important is SBP variability for prediction of renal outcomes compared with on-treatment mean SBP. We addressed these issues in 28 790 participants of the Ongoing Treatment Alone and in combination with Ramipril Global End point Trial and …
Authors
Mancia G; Schumacher H; Böhm M; Mann JFE; Redon J; Facchetti R; Schmieder RE; Lonn EM; Teo KK; Yusuf S
Journal
Journal of Hypertension, Vol. 38, No. 10, pp. 2050–2058
Publisher
Wolters Kluwer
Publication Date
October 2020
DOI
10.1097/hjh.0000000000002567
ISSN
0263-6352